Trial intelligence / Profile preview

Belbuca Phase 3 in Opioid-Experienced Chronic Low Back Pain

NCT01675167Phase 3Completed

Sponsor
BioDelivery Sciences International
Start
Sep 2012
Primary completion
Jun 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of buprenorphine in chronic low back pain (CLBP), sponsored by BioDelivery Sciences International. Started Sep 2012; status: completed.

02

Drugs

buprenorphine
03

Conditions

chronic low back pain (CLBP)

Beyond the preview

Go deeper on NCT01675167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01675167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call